The World Health Organization ( WHO ) has labelled tuberculosis as the world's leading infectious disease killer. With more ...

Scientists developed a nasal TB vaccine that boosts antibiotics, reduces relapse, lowers lung inflammation, and could improve ...

A new intranasal DNA vaccine may give the immune system an extra weapon against tuberculosis by targeting bacteria that can ...

Tuberculosis (TB) remains one of humanity’s oldest and most persistent health challenges. Despite significant medical advances, this infectious disease continues to affect millions globally, with ...

A key TB drug since the 1970s has been rifampicin. But many patients have TB strains that are resistant to it. With the BEAT ...

A new article published in Nature offers a promising path toward a shorter, more effective treatment for tuberculosis (TB), a bacterial disease that affects millions worldwide. Veronique Dartois, Ph.D ...

Over the past several decades, TB control programmes have made significant progress in expanding diagnosis and treatment ...

Tuberculosis (TB) is a major unrecognized cause of deadly sepsis among people with HIV in Africa, a sweeping new study reveals. Beginning treatment for TB immediately – even before sepsis patients are ...

FDA cleared generic rifapentine for active pulmonary TB (≥12 years) with susceptible isolates, requiring combination therapy with other active antitubercular agents. Authorization also covers LTBI (≥2 ...

The novel antibiotic candidate sorfequiline has the potential to shorten and improve tuberculosis (TB) treatment when combined with pretomanid and linezolid (SPaL), according to new clinical trial ...

Could a common over-the-counter anti-inflammatory drug become a new weapon against drug-resistant tuberculosis? Early findings suggest immune benefits, but larger trials are needed to determine ...

A four-year-old child was brought to a hospital on a ventilator after having a continuous cough for weeks and repeated ...